-
Accuray to cut 15% of workforce in transformation plan targeting $25M savings
-
Accuray (ARAY) PT Lowered to $4 at BTIG
-
Accuray (ARAY) Misses Q1 EPS by 13c ; Offers Guidance
-
Accuray names Steve La Neve CEO as Suzanne Winter retires
-
ACCURAY begins first cancer treatments with CyberKnife system in Melbourne
-
Accuray partners with University of Wisconsin on adaptive radiotherapy
-
Accuray launches Stellar radiotherapy solution for US market
-
Accuray (ARAY) PT Raised to $5 at BTIG
-
Accuray (ARAY) Reports In-Line Q4 EPS
-
Accuray (ARAY) Files for 23.43M Share Offering by Selling Stockholders
-
Accuray (ARAY) stock tumbles on debt exchange concerns
-
Accuray (ARAY) Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities
-
Accuray (ARAY) Tops Q3 EPS by 2c ; Offers Guidance
-
Accuray (ARAY) Tops Q2 EPS by 5c ; Offers Guidance
-
Accuray (ARAY) Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo C Radiation Treatment Delivery System
-
Accuray (ARAY) Appoints Leonel Peralta as COO
-
Accuray (ARAY) Announces China National Medical Products Administration Approval of the Radixact SynC™and CyberKnife S7 Systems
-
Accuray (ARAY) Tops Q1 EPS by 1c ; Offers Guidance
-
Accuray (ARAY) President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
-
Accuray (ARAY) CEO Winter to Take Temporary Medical Leave of Absence
-
Accuray (ARAY) Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix
-
Accuray (ARAY) Reports In-Line Q4 EPS, Beats on Revenue; Offers FY24 Revenue Guidance
-
Accuray (ARAY) and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support
-
Accuray (ARAY) Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

